Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
PPG Industries
PPG
$26.4B
| $1.39M | ﹤0.01% |
14,692
+11,189
| +319% | +$1.07M |
|
|
AMED
577
DELISTED
Amedisys
AMED
| $1.37M | ﹤0.01% |
32,225
-3,121
| -9% | -$133K |
|
578
Provident Financial Services
PFS
$3.11B
| $1.37M | ﹤0.01% |
48,516
-19,994
| -29% | -$498K |
|
579
Nucor
NUE
$56.4B
| $1.36M | ﹤0.01% |
22,924
+16,106
| +236% | +$901K |
|
580
CVS Health
CVS
$137B
| $1.36M | ﹤0.01% |
17,248
-391,970
| -96% | -$31.7M |
|
581
US Bancorp
USB
$98.9B
| $1.34M | ﹤0.01% |
+26,026
| New | +$1.24M |
|
|
NAVG
582
DELISTED
Navigators Group Inc
NAVG
| $1.32M | ﹤0.01% |
22,408
-600
| -3% | -$31.1K |
|
583
Accenture
ACN
$94.3B
| $1.31M | ﹤0.01% |
+11,208
| New | +$1.33M |
|
|
WBMD
584
DELISTED
WebMD Health Corp.
WBMD
| $1.31M | ﹤0.01% |
26,486
+8,319
| +46% | +$430K |
|
585
Ecolab
ECL
$76.4B
| $1.29M | ﹤0.01% |
10,999
+8,706
| +380% | +$1.02M |
|
586
Invesco
IVZ
$13.3B
| $1.28M | ﹤0.01% |
42,326
-46,487
| -52% | -$1.43M |
|
587
United Parcel Service
UPS
$96B
| $1.28M | ﹤0.01% |
+11,183
| New | +$1.26M |
|
588
Woodward
WWD
$25B
| $1.28M | ﹤0.01% |
18,536
-513
| -3% | -$33.2K |
|
|
ORBC
589
DELISTED
ORBCOMM, Inc.
ORBC
| $1.28M | ﹤0.01% |
154,678
-1,102,080
| -88% | -$9.68M |
|
|
RAI
590
DELISTED
Reynolds American Inc
RAI
| $1.27M | ﹤0.01% |
22,698
-37,769
| -62% | -$2M |
|
591
Ameris Bancorp
ABCB
$5.77B
| $1.26M | ﹤0.01% |
28,825
-779
| -3% | -$31.6K |
|
592
Newmont
NEM
$98.5B
| $1.23M | ﹤0.01% |
36,226
+28,045
| +343% | +$958K |
|
|
MRSH
593
Marsh
MRSH
$87.5B
| $1.21M | ﹤0.01% |
+17,903
| New | +$1.2M |
|
594
American International
AIG
$42B
| $1.19M | ﹤0.01% |
+18,193
| New | +$1.14M |
|
|
HF
595
DELISTED
HFF Inc.
HF
| $1.18M | ﹤0.01% |
39,032
+3,423
| +10% | +$97.6K |
|
|
TVTY
596
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.17M | ﹤0.01% |
51,227
-2,046
| -4% | -$48.1K |
|
|
WBA
597
DELISTED
Walgreens Boots Alliance
WBA
| $1.15M | ﹤0.01% |
+13,832
| New | +$1.14M |
|
598
FTI Consulting
FCN
$4.88B
| $1.14M | ﹤0.01% |
25,235
-677
| -3% | -$29.4K |
|
599
Lowe's Companies
LOW
$119B
| $1.1M | ﹤0.01% |
15,512
-576,987
| -97% | -$40.8M |
|
600
Viavi Solutions
VIAV
$9.41B
| $1.09M | ﹤0.01% |
+133,388
| New | +$1.04M |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.